PortViewPortView
Inhibrx Biosciences logo

Inhibrx Biosciences (INXBV) Stock Analysis

NASDAQHealthcareBiotechnology

$13.92-12.95%
1-year price historyRange $13.92 – $18.02
52-week range$13.92
$12.95$18.95

What Inhibrx Biosciences does

Inhibrx Biosciences, Inc. Common Stock When Issued (NASDAQ: INXBV) is a Biotechnology company in the Healthcare sector.

Key metrics

Market cap
$198.24M
P/E (TTM)
0.00
Beta
0.00
50-day avg
$16.45
200-day avg
$16.45
52-week high
$18.95
52-week low
$12.95

ETFs linked to INXBV

Broad-market and Healthcare sector ETFs an investor holding Inhibrx Biosciences is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how INXBV fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze INXBV in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for Inhibrx Biosciences?
Inhibrx Biosciences trades under the ticker INXBV on NASDAQ.
Which exchange is INXBV listed on?
INXBV is listed on NASDAQ.
What sector does Inhibrx Biosciences operate in?
Inhibrx Biosciences is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze INXBV in a portfolio?
PortView shows INXBV's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.